VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,691,000 | -10.6% | 100,000 | 0.0% | 0.40% | +10.4% |
| Q2 2023 | $3,011,000 | -6.9% | 100,000 | 0.0% | 0.36% | -20.0% |
| Q1 2023 | $3,235,000 | -5.9% | 100,000 | -16.7% | 0.46% | -15.7% |
| Q4 2022 | $3,439,200 | +18.8% | 120,000 | 0.0% | 0.54% | +2.3% |
| Q3 2022 | $2,894,000 | -11.9% | 120,000 | 0.0% | 0.53% | -7.0% |
| Q2 2022 | $3,286,000 | -28.6% | 120,000 | 0.0% | 0.57% | -18.3% |
| Q1 2022 | $4,602,000 | +19.7% | 120,000 | 0.0% | 0.70% | -31.3% |
| Q4 2021 | $3,844,000 | +8.7% | 120,000 | 0.0% | 1.01% | +116.5% |
| Q3 2021 | $3,536,000 | -13.3% | 120,000 | 0.0% | 0.47% | -20.2% |
| Q2 2021 | $4,078,000 | +4.6% | 120,000 | 0.0% | 0.58% | -8.2% |
| Q1 2021 | $3,900,000 | -9.8% | 120,000 | 0.0% | 0.64% | -20.9% |
| Q4 2020 | $4,322,000 | – | 120,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |